Sentences with phrase «director at the pharmaceutical company»

Not exact matches

Like the time he got a call from an HR director at a large pharmaceutical company that came to him on referral.

Pamela O. Kimmet Director Since: 2016 Pamela Kimmet is the Chief Human Resources Officer at Cardinal Health, Inc., a health care services company which distributes pharmaceuticals and medical products, manufactures medical and surgical products and provides logistics and other services designed to improve the cost - effectiveness of healthcare.

Mr. Jiwan has served on numerous boards of directors and advisors, including: (i) Future Finance Loan Corporation, a European private student lender that has helped students at over 130 universities fund their education, where Mr. Jiwan is a co-founder and non-executive Chairman; (ii) BFRE, a Brazilian private real estate finance company, which was subsequently sold to affiliates of BTG Pactual; (iii) GP Investimentos, one of Latin America's leading private equity firms, where he served on its shareholder advisory board; (iv) NewPoint Re, a Bermuda - based reinsurance business; and (v) Kaletra QD product development program with Abbott Pharmaceuticals, where he served on the Joint Oversight Committee.

One of the first steps taken by the program's director was to organize an advisory committee consisting of senior regulatory affairs professionals working at local pharmaceutical, biologics, and medical device companies.

«What we are likely seeing is that the model of a vertically integrated pharmaceutical company capable of taking a molecule from discovery to market is in the process of disintegrating,» says Garret FitzGerald, chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania.

Choosing London to host the court specializing in life sciences patents plays to Britain's strength in pharmaceutical research, says Richard Jennings, deputy director of Cambridge Enterprise, a company that helps commercialize inventions at the University of Cambridge in the United Kingdom (U.K.).

Merck and the Wellcome Trust call the new center a «first of its kind» and if one looks at the specifics of this union between a major pharmaceutical company and major philanthropy, that's true, agrees Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases.

His positions have included senior communications manager at Amgen, a major biopharmaceutical company; senior manager for worldwide R&D and medical communications at pharmaceutical giant Pfizer Inc.; and most recently senior communications director at a national health care policy think tank.

In a separate letter to the Corporate Secretary of the Company, the Investor is simultaneously submitting a Stockholder's Notice of Nomination of Persons for Election as Directors and Other Proposed Business at the 2009 Annual Meeting of Stockholders of Vanda Pharmaceuticals Inc., dated February 13, 2009 (the «Notice»).

ROCKVILLE, MD. — February 23, 2009 — Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)(«Vanda» or the «Company») today issued the following statement regarding two letters sent to Vanda by Tang Capital Partners, LP («TCP») and a SEC filing by TCP stating its intent to, among other things, nominate two directors to stand for election at Vanda's 2009 Annual Meeting of Stockholders and submit proposals at the 2009 Annual Meeting to amend Vanda's bylaws and request that the Board of Directors of Vanda take action to liquidate thedirectors to stand for election at Vanda's 2009 Annual Meeting of Stockholders and submit proposals at the 2009 Annual Meeting to amend Vanda's bylaws and request that the Board of Directors of Vanda take action to liquidate theDirectors of Vanda take action to liquidate the Company.

Re: Recommendations for Candidates for Election as Directors at the 2009 Annual Meeting of Stockholders of Vanda Pharmaceuticals Inc. (the «Company»)

He has also served as Director for Cancer Immunology and Immunotherapy for the Donald Monk Cancer Research Foundation; he is a partner at Veterinary Research Associates, LLC, a company focused on development and implementation of diagnostics for veterinary medicine and a founder / scientist at ApopLogic Pharmaceuticals, Inc, a biotechnology company focused on development of cancer therapeutics.

Past roles included serving as executive director, Global External R&D, at Eli Lilly and Company, where he was responsible for implementation of strategies which aim to leverage novel approaches to external partnerships to augment Lilly's access to pharmaceutical innovation as well as executive director of LRL (Lilly Research Labs) Strategy, Portfolio Management and Project Management where he was responsible for strategic planning, R&D portfolio and project management.

This September, former RB group GC Claire Debney will start at pharmaceutical giant Shire in a newly - created role of director of legal strategy, part of which will see her overhaul the FTSE 100 company's intranet and look at contract automation.

He has handled virtually every kind of case, many involving sophisticated issues and sizeable amounts at stake, representing all kinds of parties such as entrepreneurs, developers, traders, physicians, partners, shareholders, officers and directors, corporations and banks, partnerships, LLC's, hospitals, pharmaceutical companies, construction companies, software companies, accountants, law firms, art dealers, private utilities, and even pro-bono the community surrounding Wrigley Field.

The goal is to become an associate director of a preclinical department at a pharmaceutical company.